David F. Smith Eclectic Announces THE VITAMEN LEGACY as the Best Children's Book Series in the U.S. of 2025
United States, June 7, 2025 -- A Groundbreaking Approach to Teaching Health and Nutrition to Children
David F. Smith is proud to announce that The Vitamen Legacy has been named the Best Children's Book Series in the U.S. of 2025 by Best of Best Review. This revolutionary series takes an innovative approach by blending thrilling superhero adventures with essential lessons on health and nutrition. Through exciting journeys, children follow the Vitamens, a team of superheroes whose powers are fueled by vitamins and healthy nutrients. The series is designed not only to entertain young readers but also to educate them on the importance of a balanced diet and healthy lifestyle.
Each book in the series serves as a fun-filled adventure that encourages children to make healthier food choices. The educational content is seamlessly woven into each plot, making learning about vitamins and their benefits both enjoyable and memorable.
The bilingual nature of the series further broadens its reach, with both English and Spanish versions available to ensure accessibility for diverse audiences. This thoughtful approach allows children from different linguistic backgrounds to benefit from the important health lessons within the stories.
Why THE VITAMEN LEGACY is Recognized as the Best
The Vitamen Legacy stood out among hundreds of contenders for several key reasons, establishing its place as the leader in children's literature for 2025:
Highlights from the Series
Feedback from Parents, Educators, and Readers
Parents and educators have praised The Vitamen Legacy for its unique ability to make nutrition fun and accessible for children. One parent shared, 'I've never seen my kids so engaged with the concept of vitamins and healthy food choices—this series makes learning about nutrition an exciting adventure!' Teachers also appreciate the series for its bilingual format, which not only encourages language development but also allows for a more inclusive learning experience.
The characters of the Vitamens are becoming favorites among children, with young readers eagerly awaiting each new volume. The combination of superhero excitement and essential health lessons is a winning formula that resonates with both kids and adults.
Why THE VITAMEN LEGACY Should Be on Every Family's Shelf
The Vitamen Legacy provides an exceptional blend of entertainment and education that both parents and children can enjoy. Here are the key reasons to explore the series:
Parents, educators, and young readers alike can dive into this award-winning series at davidfsmitheclectic.com.
About David F. Smith Eclectic
David F. Smith Eclectic is committed to producing high-quality children's literature that educates and entertains. Through The Vitamen Legacy, the company aims to inspire the next generation to make healthier lifestyle choices while fostering a love of reading. The series is built on the belief that learning about nutrition can be both fun and impactful for young readers. David's next children's book series, available in July, is The Braces Chronicles - Adventures with Dr. B.
Media Contact
David F. Smith, Author
David F. Smith Eclectic
Email: [email protected]
Contact Info:
Name: David F. Smith
Email: Send Email
Organization: David F. Smith Eclectic
Website: https://www.davidfsmitheclectic.com/
Release ID: 89161847
In case of detection of errors, concerns, or irregularities in the content provided in this press release, or if there is a need for a press release takedown, we strongly encourage you to reach out promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our efficient team will be at your disposal for immediate assistance within 8 hours – resolving identified issues diligently or guiding you through the removal process. We take great pride in delivering reliable and precise information to our valued readers.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
12-year-old sworn in as honorary sheriff ahead of organ transplant
A 12-year-old New York boy who has kidney failure was sworn in as an honorary sheriff this week. Suffolk County Sheriff Errol D. Toulon Jr. oversaw the swearing-in ceremony of Wyatt Houppert on Tuesday, calling it an important event for everyone at the sheriff's office. "Welcoming Wyatt Houppert as 'Sheriff for the Day' was a meaningful moment for our agency," Toulon said in a statement to "Good Morning America." Son of sheriff's deputy sworn in on the same force as late father Wyatt's mom, Devan Houppert, told "GMA" they found out in 2021 that Wyatt was born with one regular kidney and another "the size of a walnut" that "had never developed." Houppert said doctors told them that over the years, Wyatt's one full-size kidney began to fail, and by February 2025, they learned both of Wyatt's kidneys had gone into failure, and he needed to be treated with hemodialysis and would eventually require a kidney transplant. According to the National Institute of Diabetes and Digestive and Kidney Diseases, hemodialysis is a treatment that helps the body filter water and waste from the bloodstream because the kidneys are unable to do so by themselves. Despite having to undergo dialysis three to four times a week for at least four hours per session, Houppert said her son has not lost hope and has kept a positive outlook for months. "Never for a second did he even consider it's not going to be OK," Houppert said. "It's always, 'We got this. Come on, let's just do it. Where's my kidney? Let's go right now.' And just so positive, just, 'It's going to be OK.'" "Many times, me and my husband have been upset sitting there, and then we're looking at him, going, 'Wait a second, we have so much to learn from this child,'" she added. "Because he's sitting there with the best attitude." Houppert said Dawn Rice, a family friend, volunteered to get evaluated to see if she could donate a kidney to Wyatt, and after testing, she said doctors surprised the family with the news that Rice was "a perfect match" for Wyatt. Rice also happens to be the wife and sister of two corrections officers with the Suffolk County Sheriff's Office, which honored her as well at Wyatt's "sheriff for the day" ceremony. "[Wyatt's] strength and courage are truly inspiring, and the selfless kidney donation by Dawn Rice reflects the compassion and unity of our Sheriff's Office family," Toulon said. 6-year-old with heart condition sworn in as honorary police officer Houppert said her 12-year-old was "over the moon" to be "sheriff for the day." "He's a very, like, stoic, serious guy. So when you get those smiles, and he's telling you, 'It's the best day ever,' you know that it really was," Houppert recalled. "He definitely took his sheriff duties very seriously all day," she added. "It was so funny hearing him telling his older brother, 'Turn the TV up. I'm the sheriff. We have to get pizza for dinner. I'm the sheriff.'" Wyatt is scheduled to undergo his kidney transplant at Hassenfeld Children's Hospital at NYU Langone in New York City on Monday. Dr. Marissa Lipton, a pediatric nephrologist in the Pediatric Kidney Transplant Program at Hassenfeld Children's Hospital, told "GMA" the kidney transplant will be life-changing for the boy. "Wyatt is an incredible kid with a wonderfully supportive family and community behind him. Our entire team at Hassenfeld Children's Hospital at NYU Langone is honored to care for him and support his family as he prepares for his transplant on Monday," Lipton said in an emailed statement. "We're looking forward to getting him off dialysis. This transplant will truly change his life, and we're so grateful to his living donor for this incredible gift," Lipton added. "We can't wait to see Wyatt back to playing outside and enjoying his video games like any active 12-year-old." Solve the daily Crossword
Yahoo
3 minutes ago
- Yahoo
Celcuity to Announce Topline Results for the PIK3CA Wild-Type Cohort from Phase 3 VIKTORIA-1 Trial in HR+/HER2- Advanced Breast Cancer
MINNEAPOLIS, July 25, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the Company will hold a conference call and webcast on Monday, July 28, 2025 at 8:00 AM ET to disclose the topline results of the PIK3CA Wild-Type Cohort from the Phase 3 VIKTORIA-1 trial. Webcast and Conference Call Information The Celcuity management team will host a webcast/conference call on Monday, July 28, 2025 at 8:00 a.m. ET to discuss the topline results from the Phase 3 VIKTORIA-1 trial. Those who would like to participate may access the live webcast here, or register in advance for the teleconference here. A replay of the webcast will be available on the Celcuity website following the live event. About Celcuity Celcuity is a clinical-stage biotechnology company pursuing development of targeted therapies for treatment of multiple solid tumor indications. The company's lead therapeutic candidate is gedatolisib, a potent, pan-PI3K and mTORC1/2 inhibitor that comprehensively blockades the PAM pathway. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3Kα, AKT, or mTORC1 alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients. A Phase 1/2 clinical trial, CELC-G-201, evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is ongoing. A Phase 3 clinical trial, VIKTORIA-2, evaluating gedatolisib plus a CDK4/6 inhibitor and fulvestrant as first-line treatment for patients with HR+/HER2- advanced breast cancer is currently enrolling patients. More detailed information about Celcuity's active clinical trials can be found at Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at Follow us on LinkedIn and X. View source version of release on Contacts: Celcuity Inc. Brian Sullivan, bsullivan@ Vicky Hahne, vhahne@ (763) 392-0123 ICR HealthcarePatti Bank, (415) 513-1284Sign in to access your portfolio
Medscape
4 minutes ago
- Medscape
Medicare at 60: Good for Doctors, Patients?
Sixty years ago, Congress passed legislation that created Medicare . In 1966, its first year of implementation, there were 19.1 million enrollees. Almost a decade later, enrollment had grown to 22.5 million. Today, 68.8 million Americans have Medicare coverage, with about half enrolled in Advantage plans. The original idea for this insurance program was even bigger, with President Harry Truman endorsing universal coverage in 1945. As Medicare turns 60, Medscape convened an expert panel to discuss the successes — and shortcomings — of this landmark insurance program. Jen Brull, MD: For everyone on the panel, how might Medicare use AI (artificial intelligence) more generally over the next 50 years? Jonathan Gruber, PhD: As with many things, there's a right level of prior authorization, and we need to let data inform that. We need to be collecting a lot of data on who's using prior authorization, how it's being used, and how productive it is. And we need to recognize that the right answer is not "zero" or "every single visit." It's somewhere in between. We need to be putting more resources into studying that and figuring out what the right level is. I want to take a slightly more optimistic view of AI in two senses. One is, I think that right now a fundamental problem in healthcare is that not all people are practicing at the top of their professional abilities. We have doctors taking blood pressure in some places; doctors should never take a blood pressure. We have nurses who are unable to give pills in some places, and nurses should be perfectly qualified to give pills. I think AI can give us more confidence in allowing people to practice at the very top of their professional abilities. The other is long-term care. Elder loneliness is a huge problem in our country; proper long-term care is a huge problem. The attacks on immigration in this country — and there are attacks — are going to make the problems worse, because many of the caregivers in the United States are immigrants. My hope is that AI can play a productive role in helping provide care for our nation's elderly and disabled. So I have a slightly optimistic view of how AI can maybe make our healthcare system better. Improving Diagnosis Norman Ornstein, PhD: Let me give a slightly optimistic view. I have regularly read in the health and science sections in the Washington Post and The New York Times these stories about people who have horrendous health issues that go on for years that are undiagnosed or misdiagnosed until somebody realizes it's some rare thing that they had never encountered before, or you find a physician who'd encountered it once and they managed to deal with it and cure it. You can imagine AI being an enormous boon to physicians, allowing them to put in symptoms that somebody's having and a little bit of history and end up finding things that siloed physicians otherwise would not see. On the other hand, you can see AI being used, and sometimes misused, by insurance companies for billing purposes or to try to find ways to save money, but also to substitute for physicians — whether that will be a good thing or a bad thing. Claudia M. Fegan, MD: I think Jon made some very important points, that there are opportunities to use AI to assist physicians in diagnostic approaches. It also would be very beneficial in terms of identifying patients. We have a lot of patients who we are not touching, and there are preventive measures that we could take. Given a certain family history, given the vital signs, their weight and their background, you could anticipate certain problems that are not addressed. And I think that can push us to make better, data-driven decisions. It's an advantage that AI can provide, and we can easily put it in the hands of clinicians who are on the front line to make good decisions about patients going forward. But I think the threat here is insurance companies who may misuse it for other purposes, whether to deny coverage to people or to try to avoid expensive treatments that might be appropriate. Brull: Certainly, as one of the two primary care specialists in this group, I would say I'm very optimistic about AI and I see that it could be a team member. I also often say that I've never seen a chatbot give a hug to a patient. And as far as I know, patients don't just come to the doctor to plug their finger in and find out what's wrong. They come to partner, and so I think all of us see optimistic futures let's start with our two nonphysicians on the panel for this question. A Public Good Do you think Medicare has been good to the American people financially? Doctors complain all the time about reimbursement rates, but do you think those rates are reasonable? Let's start with you, Dr Ornstein. Ornstein: I think physicians in many instances have found ways around the lower reimbursement rates, which has often led to many unnecessary tests or other procedures so that they can get compensated adequately. I am very fearful, going back to a point that I made earlier, if these sequesters, this is the statutory Pay-As-You-Go plan that requires big cuts in Medicare because of the deficits being run up in the reconciliation bill, they limit them to 4% a year. But you know, that could even cut reimbursement rates more, and that will create a big problem. It may mean more physicians who decline to take Medicare, and that is going to create a burden for an awful lot of people along the way. Gruber: In terms of your specific question, what has it meant for the financial health of Americans, it has unambiguously been incredible. Amazing studies show that the introduction of Medicare led to massive reductions in the financial uncertainty facing elderly Americans with their medical spending. Has it been good for doctors? Unambiguously. It has been a huge boon to their business. One thing we know from every health economic study is, if you lower prices, more people use more medical care. Medicare did that. They lowered prices and people use more medical care. It's been a huge boon to the medical industry. I think the big question going forward is how to set the rates and in a way that balances our fiscal needs against the needs to have qualified physicians participate in Medicare. Quite frankly, it seems like the direction of that is clear: Medicare overpays subspecialists and underpays primary care doctors. And that's because the panel that set Medicare rates has been politically captured by the subspecialists. I find it hard to believe that if orthopedists made $700,000 instead of $1 million per year, they'd quit Medicare. But it is plausible that a primary care physician making $150,000 or $250,000 might actually quit Medicare. These are people who could go into other lucrative professions. I want to second Claudia's call for more data. We need to really understand how physicians will respond to reimbursements, and we need to set reimbursements in a way which balances these two needs. Ornstein: Let me add one thing. Just do a thought experiment. What if we'd never had Medicare? What if we didn't have any program with government support for a population of older Americans? The number of people who would've died prematurely, the number who would've used up every portion of their assets trying to cover just basic medical care, would've been enormously high. Society would've been so much poorer overall if there had been no Medicare. And if we see assaults on these programs, we're going to go back to having bankruptcies and people who won't get the care because they can't afford it. Brull: Dr Fegan, as a physician, what are your thoughts? Fegan: I think Medicare has made a tremendous difference. And if you just want to look at the data on life expectancy for Americans compared to other wealthy nations: If you look at the top 17 wealthiest countries in the world, we are really near the bottom up until age 65. And the dramatic change that occurs after 65 in terms of life expectancy in the United States, compared to other wealthy nations, is that we shoot to the top. And this is because Medicare has provided access to care for people who didn't have access to care. For physicians, and it really depends on the population of physicians you're talking about, it guaranteed that they were going to be compensated for patients that they may have been taking care of without appropriate compensation. The majority of hospitals in this country would not survive without Medicare. The majority of patients in hospitals in the United States are Medicare recipients. I would say that prior to the Affordable Care Act, 80% of our outpatients were unfunded and 56% of our inpatients were unfunded. Now we bounce between 60% and 65% of all our patients being funded, which made a tremendous difference for us. Medicare has made being a primary care physician feasible, whereas previously it was a financially precarious situation for many of them, in terms of being compensated for the services that they were providing. They might provide services for a chicken or for a free meal, as opposed to knowing that they would be paid at the end of the day, and they would know the rate they were going be paid. The challenge with Medicare is that it pays different rates within the city. I live in Chicago, and if you have an office downtown, the rate you receive is different from if you're on the South Side or West Side. We have to look at how we make those kinds of decisions. What We Pay Our Doctors Brull: Dr Ornstein, legislation in 1993 set targets for spending growth in physician services but did not account for inflation in practice costs. Why can't Congress seem to take care of the so-called doc fix? Ornstein: I think there are two reasons. One is obviously money. It means a lot more money, and they have been at least cognizant of the problems with the solvency of the program, looking at the long run. The second is that doctors have really not been a very effective lobby. To circle back to Medicare Advantage, I'd say the prime reason reimbursement rates are 130% or whatever, when they were supposed to be 90%, is because of the effectiveness of the insurance lobby with Congress. Congress could have stepped in and done something about that. If you look even, for example, at the Affordable Care Act, it was actually then-Senator Al Franken [D-Minn.] who said, 'If you're providing coverage under the Affordable Care Act, 85% of the money that you take in has to go back to patients.' There are ways for Congress to deal with this, but they respond to the lobbying that they get and the effectiveness that they've seen. And frankly, physicians have not been very effective. The physician community was extremely effective in keeping Medicare from being enacted for decades when the [American Medical Association] was an extraordinarily powerful lobby, until the Great Society and these enormous numbers of Democrats coming into Congress in 1964 enabled it to happen. But, if we're looking at weakness in lobbying efforts, physicians are in the top 10. More Pay Cuts Brull: Another one for you, Dr Ornstein. The recently passed budget reconciliation bill includes cuts in government spending. The Congressional Budget Office projected that this will include about $500 billion in mandatory reductions in Medicare spending between 2026 and 2034, or about a 4% reduction in payments to hospitals and physicians. Congress could act to block the cuts. Do you project that they will do so? And if they do not, what may be the effect on physicians and the program over the next decade? Ornstein: It's kind of interesting. We've had these so-called pay-go rules — pay-as-you-go — in one form or another since 1990 and the budget agreement that then-President George Herbert Walker Bush enacted with Congress, which was highly controversial because it violated the 'Read my lips: no new taxes" pledge. It has worked reasonably effectively, at least at different times. But in the past, when we have seen pay-go implemented, Medicare is one of the prime elements that gets these cutbacks or sequesters. Whenever it's happened, Congress has then stepped in and ameliorated it because they saw that it was going to have a bad effect. I'm not 100% sure it's going to happen this time. And the fundamental reason is that we know Republicans, certainly going back at least to the Newt Gingrich era in the House, have wanted to take over the Medicare program. Medicare as we know it would not exist if they had had their way. It would be in some other form. The sequesters don't allow cuts in Medicaid, but they have these big cuts in Medicare, and I think it's a dicey proposition. But let's just note, Jen, that if we do see these cuts, they will hit the reimbursement rates for hospitals and for physicians. Just start with hospitals for a minute, where we know the Medicaid cuts are going to have a devastating effect, especially on rural hospitals that have already been reeling even without these cuts. What we know is that if any hospital closes, it puts enormous pressure on other hospitals, and the other hospitals are not going to get the money. They're going to cut back on services. We've seen in Atlanta, for example, where an urban hospital had to close, and every other hospital found that their emergency room services were suddenly just completely overloaded. This system looks like it's separate parts private care, Medicare, Medicaid, but they're all interrelated, and it's like a set of dominoes. If one begins to fall, the others are affected by it. These cuts would be catastrophic if they are allowed to take place, and whether enough Republicans will join with Democrats to ameliorate that, which of course then means bigger deficits, we don't know for sure.
